The impact of COVID-19 pandemic on patients with ANCA associated vasculitis.

ABSTRACT:

Introduction

The coronavirus 2019 (COVID-19) pandemic has brought on challenges not only to acute care, but also chronic care of patients. Individuals maintained on immunosuppression appear to be especially susceptible to COVID-19 infection. Patients with ANCA-associated vasculitis (AAV) frequently require immunosuppression and may be at increased risk for developing COVID-19. The incidence and impact of COVID-19 on patients with AAV is currently not known. We aimed to investigate this impact via a telephone questionnaire-based patient survey and chart review.

Methods

A cross-sectional study of AAV patients followed at two centers was conducted. Data regarding demographics, disease characteristics and therapy were confirmed by chart review. A telephone survey was conducted t

SUBMITTER: Kant S 

PROVIDER: S-EPMC7543954 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature